Загрузка...
Active immunotherapy options for Alzheimer’s disease
Alzheimer’s disease (AD) is the most common cause of dementia and a major contributor to disability and dependency among older people. AD pathogenesis is associated with the accumulation of amyloid-beta protein (Aβ) and/or hyperphosphorylated tau protein in the brain. At present, current therapies p...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3979042/ https://ncbi.nlm.nih.gov/pubmed/24476230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt237 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|